© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
September 03, 2022
Catch up on all the important news and clinical care topics you may have missed this week.
September 02, 2022
Reviewers weigh evidence for the benefit of oral PrEP protection from HIV with risk of exacerbating hepatitis B.
September 01, 2022
A new report underscores a persistent problem of patients not receiving antivirals despite their high curative rate.
August 30, 2022
A biotech company is utilizing this platform to rid people of the virus using a technology that differs from CRISPR-Cas9.
August 24, 2022
Rates of hepatitis C reinfection were low among people receiving opioid agonist therapy, according to a new study, which highlights the importance of risk reduction interventions and HCV treatment for people who inject drugs and people receiving opioid agonist therapy.
August 19, 2022
WHO guidelines on HIV, hepatitis and STIs focus on populations with high risk of infections but low inclusion in prevention and treatment programs.
August 18, 2022
WHO issues new HCV treatment recommendations that include "radical simplification" of care pathways, in pursuit of testing and treatment goals.
August 01, 2022
At AIDS 2022, Gilead presented data suggesting Biktarvy was a safe and effective complete HIV treatment regimen, including for those coinfected with hepatitis B.
July 28, 2022
What steps need taken to end viral hepatitis by 2030? “It all comes down to testing,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute.
Implicating adenovirus for hepatitis of unknown cause in children is confounded by its absence in some cases, and from all tested hepatic tissue.
Invasive Nontyphoidal Salmonellosis: An Antimicrobial-Resistant Foe
Antibiotic Stewardship in Outpatient Care
Rapid, Reliable Diagnostic and PoC Tests Are Requisite for “Test to Treat"
HCV Not Associated With Myocarditis Risks for Young HIV Patients